727 / 1119
31
Conclusion (I)
Dose effect demonstrated for:
Residual GTV D100, adaptive CTV
HR
D90, and CTV
IR
D90
Bladder D 2cm
3
Rectum D 2cm
3
Vagina (recto-vaginal point)
Dose effect not demonstrated for
Sigmoid and bowel
Dose to adhesive bowel loops may be important!
Perspective: prospective dose prescription protocol
taking into account multiple parameters:
Target dose, volume and overall treatment time